Newmont Corporation
Newmont Corporation (NEM.AX) Financial Performance & Income Statement Overview
Analyze Newmont Corporation (NEM.AX) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Newmont Corporation (NEM.AX) Income Statement & Financial Overview
View the income breakdown for Newmont Corporation NEM.AX across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.01B | $5.72B | $4.60B | $4.31B |
| Cost of Revenue | $2.70B | $3.17B | $3.15B | $2.91B |
| Gross Profit | $2.31B | $2.56B | $1.45B | $1.40B |
| Gross Profit Ratio | $0.46 | $0.45 | $0.32 | $0.33 |
| R&D Expenses | $43.00M | $48.00M | $47.00M | $49.00M |
| SG&A Expenses | $110.00M | $128.00M | $113.00M | $100.00M |
| Operating Expenses | $295.00M | $219.00M | $168.00M | $169.00M |
| Total Costs & Expenses | $2.99B | $3.38B | $3.31B | $3.08B |
| Interest Income | $41.00M | $38.00M | $37.00M | $38.00M |
| Interest Expense | $79.00M | $93.00M | $86.00M | $103.00M |
| Depreciation & Amortization | $686.00M | $693.00M | $763.00M | $696.00M |
| EBITDA | $3.24B | $2.80B | $1.91B | $1.83B |
| EBITDA Ratio | $0.65 | $0.49 | $0.41 | $0.43 |
| Operating Income | $2.02B | $2.34B | $1.28B | $1.23B |
| Operating Income Ratio | $0.40 | $0.41 | $0.28 | $0.29 |
| Other Income/Expenses (Net) | $455.00M | -$285.00M | -$226.00M | -$197.00M |
| Income Before Tax | $2.47B | $2.05B | $1.06B | $1.04B |
| Income Before Tax Ratio | $0.49 | $0.36 | $0.23 | $0.24 |
| Income Tax Expense | $647.00M | $702.00M | $244.00M | $191.00M |
| Net Income | $1.89B | $1.40B | $922.00M | $853.00M |
| Net Income Ratio | $0.38 | $0.25 | $0.20 | $0.20 |
| EPS | $1.68 | $0.02 | $0.80 | $0.74 |
| Diluted EPS | $1.68 | $0.02 | $0.80 | $0.74 |
| Weighted Avg Shares Outstanding | $1.13B | $1.15B | $1.15B | $1.15B |
| Weighted Avg Shares Outstanding (Diluted) | $1.13B | $1.15B | $1.15B | $1.16B |
Over the past four quarters, Newmont Corporation demonstrated steady revenue growth, increasing from $4.31B in Q2 2024 to $5.01B in Q1 2025. Operating income reached $2.02B in Q1 2025, maintaining a consistent 40% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $3.24B, reflecting operational efficiency. Net income rose to $1.89B, with EPS at $1.68. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan